| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
DSM Stock Overview
Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally.
Rewards
Analysts in good agreement that stock price will rise by 27%
Risk Analysis
DSM passed our risk checks.
Koninklijke DSM N.V. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €125.35 |
| 52 Week High | €200.50 |
| 52 Week Low | €108.80 |
| Beta | 0.79 |
| 1 Month Change | 0.12% |
| 3 Month Change | -6.46% |
| 1 Year Change | -35.10% |
| 3 Year Change | 7.78% |
| 5 Year Change | 61.04% |
| Change since IPO | 1,822.30% |
Recent News & Updates
Is Koninklijke DSM (AMS:DSM) Using Too Much Debt?
Nov 18
Estimating The Fair Value Of Koninklijke DSM N.V. (AMS:DSM)
Oct 31Recent updates
Is Koninklijke DSM (AMS:DSM) Using Too Much Debt?
Nov 18Estimating The Fair Value Of Koninklijke DSM N.V. (AMS:DSM)
Oct 31Why Koninklijke DSM N.V. (AMS:DSM) Could Be Worth Watching
Sep 19Is Now The Time To Put Koninklijke DSM (AMS:DSM) On Your Watchlist?
Aug 23Is Koninklijke DSM (AMS:DSM) Using Too Much Debt?
Aug 08Calculating The Intrinsic Value Of Koninklijke DSM N.V. (AMS:DSM)
Jul 23Koninklijke DSM (AMS:DSM) Is Increasing Its Dividend To €1.70
Apr 30Koninklijke DSM (AMS:DSM) Is Increasing Its Dividend To €1.70
Apr 16Koninklijke DSM's (AMS:DSM) Upcoming Dividend Will Be Larger Than Last Year's
Apr 02Koninklijke DSM's (AMS:DSM) Dividend Will Be Increased To €1.70
Mar 19Koninklijke DSM (AMS:DSM) Seems To Use Debt Rather Sparingly
Feb 19Are Koninklijke DSM N.V. (AMS:DSM) Investors Paying Above The Intrinsic Value?
Nov 23We Think Koninklijke DSM (AMS:DSM) Can Stay On Top Of Its Debt
Oct 01Does This Valuation Of Koninklijke DSM N.V. (AMS:DSM) Imply Investors Are Overpaying?
Aug 24Koninklijke DSM (AMS:DSM) Has A Pretty Healthy Balance Sheet
Jun 29Koninklijke DSM N.V.'s (AMS:DSM) Intrinsic Value Is Potentially 17% Below Its Share Price
May 24Is Koninklijke DSM (AMS:DSM) A Risky Investment?
Mar 29Should Koninklijke DSM N.V. (AMS:DSM) Be Part Of Your Dividend Portfolio?
Mar 15Are Koninklijke DSM N.V.'s (AMS:DSM) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Mar 01Koninklijke DSM (AMS:DSM) Has Gifted Shareholders With A Fantastic 276% Total Return On Their Investment
Feb 16Need To Know: Koninklijke DSM N.V. (AMS:DSM) Insiders Have Been Selling Shares
Feb 04
Shareholder Returns
| DSM | NL Chemicals | NL Market | |
|---|---|---|---|
| 7D | -1.7% | 1.3% | 1.2% |
| 1Y | -35.1% | -23.4% | -15.5% |
Return vs Industry: DSM underperformed the Dutch Chemicals industry which returned -24.4% over the past year.
Return vs Market: DSM underperformed the Dutch Market which returned -18% over the past year.
Price Volatility
| DSM volatility | |
|---|---|
| DSM Average Weekly Movement | 4.8% |
| Chemicals Industry Average Movement | 4.7% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in NL Market | 8.1% |
| 10% least volatile stocks in NL Market | 3.0% |
Stable Share Price: DSM is not significantly more volatile than the rest of Dutch stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: DSM's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1902 | 21,760 | Dimitri de Vreeze | https://www.dsm.com |
Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, premixes, carotenoids, enzymes, microbes, and eubiotics; human nutrition and health products comprising vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics, and prebiotics, as well as active pharmaceutical ingredients; premix, market-ready solutions, and personalized nutrition; human milk oligosaccharides; and skin and sun care, hair care, and aroma ingredients; omega-3 fatty acids; and specialty food enzymes, cultures, bio-preservation, texturizing hydrocolloids, sugar reduction, and savory taste solutions.
Koninklijke DSM N.V. Fundamentals Summary
| DSM fundamental statistics | |
|---|---|
| Market Cap | €21.68b |
| Earnings (TTM) | €1.08b |
| Revenue (TTM) | €9.80b |
20.0x
P/E Ratio2.2x
P/S RatioIs DSM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DSM income statement (TTM) | |
|---|---|
| Revenue | €9.80b |
| Cost of Revenue | €6.48b |
| Gross Profit | €3.33b |
| Other Expenses | €2.24b |
| Earnings | €1.08b |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
Feb 16, 2023
| Earnings per share (EPS) | 6.26 |
| Gross Margin | 33.92% |
| Net Profit Margin | 11.04% |
| Debt/Equity Ratio | 31.4% |
How did DSM perform over the long term?
See historical performance and comparison